In line with these findings, the current study demonstrated that RAD23B overexpression notably increased MMP9 expression, suggesting that RAD23B promotes ECM degradation through MMP9 upregulation, enabling CRC cells to penetrate surrounding tissues and form distant metastases. The gene discussed is RAD23B; the disease is colorectal carcinoma.